{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:30:53Z","timestamp":1769272253578,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Medical Science Research Program Foundation","award":["No.20240185"],"award-info":[{"award-number":["No.20240185"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10142-025-01729-4","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T01:18:40Z","timestamp":1762564720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative single-cell and bulk RNA-seq analysis identifies glycosyltransferases-related signature in triple negative breast cancer"],"prefix":"10.1007","volume":"25","author":[{"given":"Junyi","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningning","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenglan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yancheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohan","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianli","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guowei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,8]]},"reference":[{"issue":"5","key":"1729_CR1","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","volume":"27","author":"A Bassez","year":"2021","unstructured":"Bassez A, Vos H, Van Dyck L, Floris G, Arijs I, Desmedt C et al (2021) A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nat Med 27(5):820\u2013832","journal-title":"Nat Med"},{"issue":"2","key":"1729_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L (2022) Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat Rev Clin Oncol 19(2):91\u2013113","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"1729_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow A, Perica K, Klebanoff CA, Wolchok JD (2022) Clinical implications of T cell exhaustion for cancer immunotherapy. Nat Rev Clin Oncol 19(12):775\u2013790","journal-title":"Nat Rev Clin Oncol"},{"issue":"17","key":"1729_CR4","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.2165\/11538150-000000000-00000","volume":"70","author":"S Dawood","year":"2010","unstructured":"Dawood S (2010) Triple-negative breast cancer: epidemiology and management options. Drugs 70(17):2247\u20132258","journal-title":"Drugs"},{"issue":"24","key":"1729_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS (2022) Pathogenesis of triple-negative breast cancer. Annu Rev Pathol 17(24):181\u2013204","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"1729_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10549-017-4537-5","volume":"167","author":"LY Dirix","year":"2018","unstructured":"Dirix LY, Takacs I, Jerusalem G, Nikolinakos P, Arkenau HT, Forero-Torres A et al (2018) Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN solid tumor study. Breast Cancer Res Treat 167(3):671\u2013686","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1729_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1017\/S0029665118002884","volume":"78","author":"Y Dunneram","year":"2019","unstructured":"Dunneram Y, Greenwood DC, Cade JE (2019) Diet, menopause and the risk of ovarian, endometrial and breast cancer. Proc Nutr Soc 78(3):438\u2013448","journal-title":"Proc Nutr Soc"},{"issue":"5","key":"1729_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrc3916","volume":"15","author":"H Gaillard","year":"2015","unstructured":"Gaillard H, Garc\u00eda-Muse T, Aguilera A (2015) Replication stress and cancer. Nat Rev Cancer 15(5):276\u2013289","journal-title":"Nat Rev Cancer"},{"issue":"10074","key":"1729_CR9","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck N, Gnant M (2017) Breast cancer. Lancet 389(10074):1134\u20131150","journal-title":"Lancet"},{"key":"1729_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2017.07.002","volume":"32","author":"H Jia","year":"2017","unstructured":"Jia H, Truica CI, Wang B, Wang Y, Ren X, Harvey HA et al (2017) Immunotherapy for triple-negative breast cancer: existing challenges and exciting prospects. Drug Resist Updat 32:1\u201315","journal-title":"Drug Resist Updat"},{"issue":"9","key":"1729_CR11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1080\/15384101.2022.2034254","volume":"21","author":"Y Jin","year":"2022","unstructured":"Jin Y, Xu L, Zhao B, Bao W, Ye Y, Tong Y et al (2022) Tumour-suppressing functions of the lncRNA MBNL1-AS1\/miR-889-3p\/KLF9 axis in human breast cancer cells. Cell Cycle 21(9):908\u2013920","journal-title":"Cell Cycle"},{"issue":"4","key":"1729_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/jnccn.2020.7554","volume":"18","author":"TE Keenan","year":"2020","unstructured":"Keenan TE, Tolaney SM (2020) Role of immunotherapy in triple-negative breast cancer. J Natl Compr Canc Netw 18(4):479\u2013489","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"1729_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1186\/s12859-022-05109-8","volume":"23","author":"JX Liang","year":"2022","unstructured":"Liang JX, Chen Q, Gao W, Chen D, Qian XY, Bi JQ et al (2022) A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma. BMC Bioinformatics 23(1):562","journal-title":"BMC Bioinformatics"},{"key":"1729_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102043","author":"T Liao","year":"2025","unstructured":"Liao T, Zeng Y, Xu W, Shi X, Shen C, Du Y et al (2025) A spatially resolved transcriptome landscape during thyroid cancer progression. Cell Rep Med. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102043","journal-title":"Cell Rep Med"},{"key":"1729_CR15","doi-asserted-by":"crossref","unstructured":"Li C, Du L, Ren Y, Liu X, Jiao Q, Cui D et al SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination. J Exp Clin Cancer Res 38(1):76","DOI":"10.1186\/s13046-019-1069-3"},{"issue":"2","key":"1729_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ccell.2018.01.009","volume":"33","author":"CW Li","year":"2018","unstructured":"Li CW, Lim SO, Chung EM, Kim YS, Park AH, Yao J et al (2018) Eradication of triple-negative breast cancer cells by targeting glycosylated PD-L1. Cancer Cell 33(2):187-201.e10","journal-title":"Cancer Cell"},{"issue":"7","key":"1729_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.872","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Lin Y, Aye L, Dong L, Zhang C, Chen F et al (2022) An integrative pan-cancer analysis of the molecular and biological features of glycosyltransferases. Clin Transl Med 12(7):e872","journal-title":"Clin Transl Med"},{"issue":"1","key":"1729_CR18","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu L, Weng S, Guo C, Dang Q, Xu H et al (2022) Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat Commun 13(1):816","journal-title":"Nat Commun"},{"issue":"23","key":"1729_CR19","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.3390\/cells11233728","volume":"11","author":"W Ma","year":"2022","unstructured":"Ma W, Zhu L, Song S, Liu B, Gu J (2022) Identification and Validation of Glycosyltransferases Correlated with Cuproptosis as a Prognostic Model for Colon Adenocarcinoma. Cells 11(23):3728","journal-title":"Cells"},{"issue":"4","key":"1729_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/path.4483","volume":"235","author":"SL Maguire","year":"2015","unstructured":"Maguire SL, Leonidou A, Wai P, Marchi\u00f2 C, Ng CK, Sapino A et al (2015) SF3B1 mutations constitute a novel therapeutic target in breast cancer. J Pathol 235(4):571\u2013580","journal-title":"J Pathol"},{"issue":"8","key":"1729_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/10408363.2019.1653821","volume":"56","author":"F Moosavi","year":"2019","unstructured":"Moosavi F, Giovannetti E, Saso L, Firuzi O (2019) HGF\/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers. Crit Rev Clin Lab Sci 56(8):533\u2013566","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"9","key":"1729_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fonc.2019.00380","volume":"14","author":"A Peixoto","year":"2019","unstructured":"Peixoto A, Relvas-Santos M, Azevedo R, Santos LL, Ferreira JA (2019) Protein glycosylation and tumor microenvironment alterations driving cancer hallmarks. Front Oncol 14(9):380","journal-title":"Front Oncol"},{"key":"1729_CR23","doi-asserted-by":"crossref","unstructured":"Pucci M, Duca M, Malagolini N, Dall\u2019Olio F (2020) Glycosyltransferases in cancer: prognostic biomarkers of survival in patient cohorts and impact on malignancy in experimental models. Cancers (Basel) 14(9):2128","DOI":"10.3390\/cancers14092128"},{"issue":"12","key":"1729_CR24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","volume":"21","author":"KT Schjoldager","year":"2020","unstructured":"Schjoldager KT, Narimatsu Y, Joshi HJ, Clausen H (2020) Global view of human protein glycosylation pathways and functions. Nat Rev Mol Cell Biol 21(12):729\u2013749","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"1729_CR25","first-page":"87","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87\u2013108","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"1729_CR26","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80150","volume":"25","author":"L Wang","year":"2022","unstructured":"Wang L, Liu Z, Liang R, Wang W, Zhu R, Li J et al (2022) Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer. Elife 25(11):e80150","journal-title":"Elife"},{"issue":"1\u20132","key":"1729_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10495-022-01784-3","volume":"28","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhang L, Sun XL, Lu YC, Chen S, Pei DS et al (2023) NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer. Apoptosis 28(1\u20132):233\u2013246","journal-title":"Apoptosis"},{"issue":"12","key":"1729_CR28","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nchembio.1403","volume":"9","author":"MA Wolfert","year":"2013","unstructured":"Wolfert MA, Boons GJ (2013) Adaptive immune activation: glycosylation does matter. Nat Chem Biol 9(12):776\u2013784","journal-title":"Nat Chem Biol"},{"key":"1729_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cca.2019.05.015","volume":"495","author":"Y Wu","year":"2019","unstructured":"Wu Y, Chen X, Wang S, Wang S (2019) Advances in the relationship between glycosyltransferases and multidrug resistance in cancer. Clin Chim Acta 495:417\u2013421","journal-title":"Clin Chim Acta"},{"key":"1729_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107164","volume":"163","author":"J Wu","year":"2023","unstructured":"Wu J, Zhou X, Ren J, Zhang Z, Ju H, Diao X et al (2023) Glycosyltransferase-related prognostic and diagnostic biomarkers of uterine corpus endometrial carcinoma. Comput Biol Med 163:107164","journal-title":"Comput Biol Med"},{"key":"1729_CR31","doi-asserted-by":"crossref","unstructured":"Yang C, Huang X, Li Y, Chen J, Lv Y, Dai S (2021) Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology. Brief Bioinform 22(3):bbaa164","DOI":"10.1093\/bib\/bbaa164"},{"key":"1729_CR32","doi-asserted-by":"crossref","unstructured":"Yin L, Dua\u00a0JJ, Bian XW, Yu S Cang (2020) Triple-negative breast cancer molecular\u00a0subtyping and treatment progress. Breast Cancer Res 22(1):61","DOI":"10.1186\/s13058-020-01296-5"},{"key":"1729_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8446857","volume":"2022","author":"B Ying","year":"2022","unstructured":"Ying B, Xu W, Nie Y, Li Y (2022) HSPA8 is a new biomarker of triple negative breast cancer related to prognosis and immune infiltration. Dis Markers 2022:8446857","journal-title":"Dis Markers"},{"key":"1729_CR34","doi-asserted-by":"publisher","first-page":"1009789","DOI":"10.3389\/fimmu.2022.1009789","volume":"13","author":"L Yu","year":"2022","unstructured":"Yu L, Shen N, Shi Y, Shi X, Fu X, Li S et al (2022) Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data. Front Immunol 13:1009789","journal-title":"Front Immunol"},{"key":"1729_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1154410","volume":"14","author":"P Zhang","year":"2023","unstructured":"Zhang P, Pei S, Gong Z, Ren Q, Xie J, Liu H et al (2023) The integrated single-cell analysis developed a lactate metabolism-driven signature to improve outcomes and immunotherapy in lung adenocarcinoma. Front Endocrinol (Lausanne) 14:1154410","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1729_CR36","first-page":"10","volume":"1","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhang G, Xu P, Yu F, Li L, Huang R et al (2025a) Optimized dynamic network biomarker deciphers a high-resolution heterogeneity within thyroid cancer molecular subtypes. Med Res 1(1):10\u201331","journal-title":"Med Res"},{"issue":"2","key":"1729_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010787","volume":"13","author":"P Zhang","year":"2025","unstructured":"Zhang P, Wang D, Zhou G, Jiang S, Zhang G, Zhang L et al (2025b) Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma. J Immunother Cancer 13(2):e010787","journal-title":"J Immunother Cancer"},{"key":"1729_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.701006","volume":"12","author":"WT Zhou","year":"2021","unstructured":"Zhou WT, Jin WL (2021) B7\u2013H3\/CD276: an emerging cancer immunotherapy. Front Immunol 12:701006","journal-title":"Front Immunol"},{"key":"1729_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.902378","volume":"10","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Che Y, Fu Z, Zhang H, Wu H (2022) Triple-negative breast cancer analysis based on metabolic gene classification and immunotherapy. Front Public Health 10:902378","journal-title":"Front Public Health"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01729-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-025-01729-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01729-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:08:38Z","timestamp":1769155718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-025-01729-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1729"],"URL":"https:\/\/doi.org\/10.1007\/s10142-025-01729-4","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,8]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not involve human or animal data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No individual personal data or images were included in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"233"}}